Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/1494
Title: Disodium cromolyn and anti-podoplanin antibodies strongly inhibit growth of BHK 21/C13-derived fibrosarcoma in a chick embryo chorioallantoic membrane model
Authors: Maria Anca Cimpean
Dušan Lalošević 
Vesna Lalošević 
Pavle Banović 
Marius Raica
Alexandru Ovidiu Mederle
Keywords: BHK 21/C13 cell line;chick embryo chorioallantoic membrane;experimental therapy;phenotype characterization
Issue Date: 1-Jul-2018
Journal: In Vivo
Abstract: © 2018 Universidade Federal Rural do Semi-Arido. All Rights Reserved. Aim: To characterize baby hamster kidney fibroblast (BHK 21/C13) cells and test the effects of antibodies against podoplanin and disodium cromolyn on BHK 21/C13 cell line-derived tumors grown on chick embryo chorioallantoic membrane (CAM). Material and Methods: BHK 21/C13 cell-derived fibrosarcomas developed in hamsters were implanted on CAM and treated with anti-podoplanin antibodies and disodium cromolyn. BHK 21/C13 cell immunophenotype was assessed. Results: Fibrosarcoma cells were positive for vimentin, CD117, smooth muscle actin, vascular endothelial growth factor epidermal growth factor receptor, homebox prospero gene 1 and negative for platelet-derived growth factor B, neuron-specific enolase, S100, CD34, Ewing sarcoma and podoplanin. CAM-grown fibrosarcomas were highly sensitive to disodium cromolyn and anti-podoplanin antibodies. Conclusion: Immunophenotyping BHK 21/C13 cells and their response to drugs represent the first step in revealing cell line utility and a reliable tool for experimental cancer research.
URI: https://open.uns.ac.rs/handle/123456789/1494
ISSN: 0258851X
DOI: 10.21873/invivo.11309
Appears in Collections:POLJF Publikacije/Publications

Show full item record

SCOPUSTM   
Citations

6
checked on May 10, 2024

Page view(s)

32
Last Week
14
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.